Lauren Ritterhouse
Harvard University
H-index: 30
North America-United States
Top articles of Lauren Ritterhouse
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of …
Archives of Pathology & Laboratory Medicine
2024/4/16
Mari Mino-Kenudson
H-Index: 69
Lauren Ritterhouse
H-Index: 20
Liquid biopsy‐based circulating tumour (ct) DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results
Histopathology
2024/2/29
Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real …
JCO oncology practice
2024/1
Prognostic biomarkers for survival in mucosal melanoma
Pigment Cell & Melanoma Research
2023/9
Real-world testing and treatment patterns among patients with stage IV non-small cell lung cancer: A retrospective observational study.
2023/6/1
Lauren Ritterhouse
H-Index: 20
Pigmentation status as a Prognostic Biomarker for Survival in Mucosal Melanoma
Laryngo-Rhino-Otologie
2023/5
Adam Fisch
H-Index: 6
Lauren Ritterhouse
H-Index: 20
Slide-to-slide tissue transfer and array assembly from limited samples for comprehensive molecular profiling
Laboratory Investigation
2023/5/1
Abstract CT155: Long term results and ctDNA correlatives for CAPOX BETR: A multi-center phase II trial of capecitabine, oxaliplatin, bevacizumab and trastuzumab for previously …
Cancer Research
2023/4/14
Abstract CT228: Concordance between tissue and circulating tumor DNA (ctDNA) testing for neurotrophic tyrosine receptor kinase (NTRK) gene fusions in …
Cancer Research
2023/4/14
Seize the opportunity with small tissue samples: The tailor teaches!
JTO Clinical and Research Reports
2023/4/1
Primary Resistance to Larotrectinib in a Patient with Squamous NSCLC With Subclonal NTRK1 Fusion: Case Report
JTO Clinical and Research Reports
2023/4/1
Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML
Clinical Chemistry and Laboratory Medicine (CCLM)
2023/3/28
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series
The Oncologist
2023/2/1
Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study
International Journal of Gynecological Pathology
2023/1/1
Implementation and clinical adoption of precision oncology workflows across a healthcare network
The Oncologist
2022/11/1
ERBB2 (HER2) alterations in colorectal cancer
The Journal of Molecular Diagnostics
2022/10/1
Molecular biomarkers of response to cancer immunotherapy
2022/9/1
MET exon 14 skipping mutations: essential considerations for current management of non–small-cell lung cancer
The Journal of Molecular Diagnostics
2022/8/1
CDK4/6 inhibition (CDK4/6i) is effective in the real-world setting for hormone receptor-positive metastatic breast cancer (HR+ MBC) with ESR1 mutations and fusions
Cancer Research
2022/6/15
Abstract CT545: Variability in NTRK gene fusions does not appear to impact response to larotrectinib
Cancer Research
2022/6/15
Lauren Ritterhouse
H-Index: 20
Chi Chen
H-Index: 34
Ray Mcdermott
H-Index: 21
Theodore W Laetsch
H-Index: 24
